Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2006
11/08/2006EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
11/08/2006CN1860228A Staple type oligonucleotide and drug comprising the same
11/08/2006CN1859906A Composition containing retinoic acid nanoparticles coated with polyvalent metal inorganic salt
11/08/2006CN1857720A Freeze dried human cell fibronection powder and its preparing method
11/08/2006CN1857719A Skin ulcer treating method
11/08/2006CN1857703A Hair nourishing pollen liquid and its preparing method
11/08/2006CN1857700A Alopecia treating Chinese medicine preparation
11/08/2006CN1857696A Chinese herbal medicine foot lotion
11/08/2006CN1857688A Fumigant for treating condyloma acuminata and its preparing method
11/08/2006CN1857676A Zedoary oil microcapsule preparation and its preparing process
11/08/2006CN1857668A Chloasma treating Chinese medicine preparation
11/08/2006CN1857667A Psoriasis treating Chinese medicine preparation
11/08/2006CN1857585A Eczema treating Chinese medicine preparation
11/08/2006CN1857573A Medicine for treating skin diseases
11/08/2006CN1857564A Bock greenbrier rhizome liquid capsule and its preparing method
11/08/2006CN1857560A Fumigant for treating anal fissure and its preparing method
11/08/2006CN1857553A Wound healing medicine
11/08/2006CN1857543A Externally applied Chinese medicine liniment for treating skin diseases
11/08/2006CN1857525A Chinese medicine and Western medicine combining hair restorer tincture and its preparing method
11/08/2006CN1857517A Frostbite treating soak and its preparing method
11/08/2006CN1857516A Compound Chinese medicine preparation for dispelling wind and damp, promoting blood circulation and removing toxic matter and its preparing process
11/08/2006CN1857515A Skin care Chinese medicine film preparation and its preparing process
11/08/2006CN1857513A Chinese medicine composition for strengthening immunity, beautifying and treating skin disease
11/08/2006CN1857504A Externally applied medicine for treating acute eczema and its preparing method
11/08/2006CN1857503A Externally applied Chinese medicine preparation for treating eczema, tinea of feet and hands, vaginitis, etc and its preparing process
11/08/2006CN1857501A Fumigant for treating perianal abscess and its preparing method
11/08/2006CN1857500A Fumigant for treating anus eczema and its preparing method
11/08/2006CN1857493A Antiseptic for preventing and treating tinea unguium and tinea of feet and hands
11/08/2006CN1857444A Chinese medicine composition and its application in health pillow and health pillow
11/08/2006CN1857430A Externally applied Chinese medicine preparation for treating burns and scalds and its preparing process
11/08/2006CN1857390A Lotion for preventing and treating gynecopathy and its preparing method
11/08/2006CN1857389A Smell foot treating soak
11/08/2006CN1857384A Liniment for treating rhagades of hand and foot and its preparing method
11/08/2006CN1857376A Medicine for treating Acne and its preparing method
11/08/2006CN1857372A Facial freckly treating fumigant and its preparing method
11/08/2006CN1857336A Soak medicine for treating tinea manus and its preparing method
11/08/2006CN1857318A Compound Chinese medicine prepn for fast healing trauma and its preparing method
11/08/2006CN1857316A Chinese medicine for treating trauma, burns and scalds
11/08/2006CN1857291A Externally applied liquid asiaticoside preparation and its preparing process
11/08/2006CN1857278A Externally applied compound gel and its preparing method
11/08/2006CN1857276A Medicine composition for treating valval and/or vaginal diseases
11/08/2006CN1857268A Minoxidil solution and preparing method of minoxidil liniment tablet
11/08/2006CN1857249A Antibacterial and antiphlogistic Chinese medicine injection and its preparing process
11/08/2006CN1283798C Polypeptides and polynucleotides from coagulase-negative staphylocoui
11/08/2006CN1283662C Antagonistic anti-hFAS ligand human antibodies and fragments thereof
11/08/2006CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006CN1283635C Heterocyclic retinoid compounds
11/08/2006CN1283622C Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
11/08/2006CN1283621C Alkyl urea vitamin A protagonist I
11/08/2006CN1283299C Combination of Chinese traditional medicine for nourishing skin and health preservation, and preparation method
11/08/2006CN1283290C External burn cream
11/08/2006CN1283285C Acne treating ointment
11/08/2006CN1283268C Compound dandelion freeze dried powder injection and its preparation method
11/08/2006CN1283261C Water-soluble propolis liquor and its preparation method
11/08/2006CN1283260C Medicine for treating psoriasis and its preparation method
11/08/2006CN1283254C Use of 23-hydroxy betulic acid in preparing administrative and/or preventive drugs for inhibiting blood vessel formation
11/08/2006CN1283224C Hair lotion stimulating hair growth
11/07/2006US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006US7132457 Adamantane derivatives
11/07/2006US7132451 Inhibition of TNF-α-initiated neutrophil response
11/07/2006US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006US7132438 Benzimidazole derivatives
11/07/2006US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/07/2006US7132415 Especially a substituted azetidinone compound
11/07/2006US7132412 Treatment of skin diseases using a pharmaceutical preparation in colloidal form
11/07/2006US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
11/07/2006CA2281755C Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/07/2006CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006CA2261988C Mannose-6-phosphate composition and its use in treating fibrotic disorders
11/05/2006WO2006103110A1 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition
11/02/2006WO2006115221A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006WO2006115193A1 Remedy for xanthoma
11/02/2006WO2006115188A1 Heterocyclic compound
11/02/2006WO2006115187A1 Pharmaceutical for prevention or treatment of bone metabolic disease
11/02/2006WO2006114657A1 Lys-thr dipeptides and their use
11/02/2006WO2006087077A3 Hsp90-inhibiting triazole derivatives
11/02/2006WO2006075350A3 Use of the pof1 gene product for cosmetic and/or therapeutic use of skin associated disorders
11/02/2006WO2006072809A3 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions
11/02/2006US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006US20060247313 administering to a osteoporosis patient an effective amount of a amino acid formulation containing 10 to 40 parts by weight of L-arginine or L-glutamine; 5 to 20 parts of L-valine; 8 to 30 parts of L-isoleucine; and10 to 35 parts of L-leucine; regeneration of tendon and ligamet; antiaging of skin
11/02/2006US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006US20060247268 N-sulfonylaminothiazole
11/02/2006US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006US20060247261 Pyrimidine compounds
11/02/2006US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006US20060247214 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
11/02/2006US20060247204 New therapeutic use of chondroitin sulphate
11/02/2006US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006US20060247183 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
11/02/2006US20060247162 Skin collagen production promoter
11/02/2006US20060246074 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, in combination with alpha 1- antitrypsin polypeptides, or nucleic acids encoding them, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds
11/02/2006US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006US20060246026 Barrier formulation comprising a silicone based emulsion
11/02/2006US20060246024 Method for stimulating hair follicle cell proliferation